GenFleet Therapeutics (Shanghai) (HKSE:02595) PEG Ratio: N/A (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02595 GenFleet Therapeutics (Shanghai) Inc HKSE:02595
10 GF Score
Price HK$27.60
! 3 Warning Signs
View Full Analysis

What is GenFleet Therapeutics (Shanghai) PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, GenFleet Therapeutics (Shanghai)'s PE Ratio without NRI is 0.00. GenFleet Therapeutics (Shanghai)'s 5-Year EBITDA growth rate is 0.00%. Therefore, GenFleet Therapeutics (Shanghai)'s PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for GenFleet Therapeutics (Shanghai)'s PEG Ratio or its related term are showing as below:



HKSE:02595's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.835
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

GenFleet Therapeutics (Shanghai)  (HKSE:02595) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

GenFleet Therapeutics (Shanghai) PEG Ratio Related Terms

GenFleet Therapeutics (Shanghai) PEG Ratio Historical Data

* Premium members only.

The historical data trend for GenFleet Therapeutics (Shanghai)'s PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenFleet Therapeutics (Shanghai) PEG Ratio Chart

GenFleet Therapeutics (Shanghai) Annual Data
Trend Dec23 Dec24 Dec25
PEG Ratio
0.00 0.00 0.00

GenFleet Therapeutics (Shanghai) Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio 0.00 0.00 0.00 0.00 0.00

HKSE:02595 vs VRTX, REGN, RVMD: PEG Ratio Comparison

For the Biotechnology subindustry, GenFleet Therapeutics (Shanghai)'s PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GenFleet Therapeutics (Shanghai) PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GenFleet Therapeutics (Shanghai)'s PEG Ratio distribution charts can be found below:

* The bar in red indicates where GenFleet Therapeutics (Shanghai)'s PEG Ratio falls into.


HKSE:02595
10GF Score
GenFleet Therapeutics (Shanghai) Inc HKSE:02595
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenFleet Therapeutics (Shanghai) PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

GenFleet Therapeutics (Shanghai)'s PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

GenFleet Therapeutics (Shanghai) Business Description

Other Exchanges Y3L:Germany
Address 1206 Zhangjiang Road, Floors 2nd, 3rd, 4th, and 5th, Building 8, Shanghai Pilot Free Trade Zone, Shanghai, CHN, 201203
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
10GF Score

Get the complete analysis for HKSE:02595

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$27.60
Price